Kathleen Larrimer Beckmann
Keine laufenden Positionen mehr
Karriereverlauf von Kathleen Larrimer Beckmann
Ehemalige bekannte Positionen von Kathleen Larrimer Beckmann
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Finanzdirektor/CFO | - | - |
Ausbildung von Kathleen Larrimer Beckmann
| Stanford Graduate School of Business | Masters Business Admin |
| Princeton University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |